Customizing G Protein-Coupled Receptor Models for Structure-Based Virtual Screening

被引:58
作者
de Graaf, Chris [1 ]
Rognan, Didier [1 ]
机构
[1] Univ Strasbourg, CNRS, UdS, Lab Therapeut Innovat,Struct Chemogenom Grp,UMR72, F-67400 Illkirch Graffenstaden, France
关键词
GPCR; modeling; virtual screening; drug design; A(2A) ADENOSINE RECEPTOR; BETA-ADRENERGIC-RECEPTOR; MOLECULAR INTERACTION FINGERPRINTS; SITE-DIRECTED MUTAGENESIS; 2ND EXTRACELLULAR LOOP; HISTAMINE H4 RECEPTOR; X-RAY-STRUCTURE; LIGAND-BINDING; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE;
D O I
10.2174/138161209789824786
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review will focus on the construction, refinement, and validation of G Protein-coupled receptor models for the purpose of structure-based virtual screening. Practical tips and tricks derived from concrete modeling and virtual screening exercises to overcome the problems and pitfalls associated with the different steps of the receptor modeling workflow will be presented. These examples will not only include rhodopsin-like (class A), but also secretine-like (class B), and glutamate-like (class C) receptors. In addition, the review will present a careful comparative analysis of current crystal structures and their implication on homology modeling. The following themes will be discussed: i) the use of experimental anchors in guiding the modeling procedure; ii) amino acid sequence alignments; iii) ligand binding mode accommodation and binding cavity expansion; iv) proline-induced kinks in transmembrane helices; v) binding mode prediction and virtual screening by receptor-ligand interaction fingerprint scoring; vi) extracellular loop modeling; vii) virtual filtering schemes. Finally, an overview of several successful structure-based screening shows that receptor models, despite structural inaccuracies, can be efficiently used to find novel ligands.
引用
收藏
页码:4026 / 4048
页数:23
相关论文
共 167 条
[1]   High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation [J].
Altenbach, Christian ;
Kusnetzow, Ana Karin ;
Ernst, Oliver P. ;
Hofmann, Klaus Peter ;
Hubbell, Wayne L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (21) :7439-7444
[2]   A compendium of specific motifs for diagnosing GPCR subtypes [J].
Attwood, TK .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (04) :162-165
[3]   Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor [J].
Bailey, R. J. ;
Hay, D. L. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (05) :678-687
[4]  
Ballesteros J. A., 1995, METH NEUROSCI, P366, DOI [DOI 10.1016/S1043-9471, DOI 10.1016/S1043-9471(05)80049-7]
[5]   Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6 [J].
Ballesteros, JA ;
Jensen, AD ;
Liapakis, G ;
Rasmussen, SGF ;
Shi, L ;
Gether, U ;
Javitch, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :29171-29177
[6]   Structural mimicry in G protein-coupled receptors: Implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors [J].
Ballesteros, JA ;
Shi, L ;
Javitch, JA .
MOLECULAR PHARMACOLOGY, 2001, 60 (01) :1-19
[7]   Hot-spots-guided receptor-based pharmacophores (HS-Pharm): A knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores [J].
Barillari, Caterina ;
Marcou, Gilles ;
Rognan, Didier .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (07) :1396-1410
[8]   In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination [J].
Bayry, Jagadeesh ;
Tchilian, Elma Z. ;
Davies, Matthew N. ;
Forbes, Emily K. ;
Draper, Simon J. ;
Kaveri, Srini V. ;
Hill, Adrian V. S. ;
Kazatchkine, Michel D. ;
Beverley, Peter C. L. ;
Flower, Darren R. ;
Tough, David F. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (29) :10221-10226
[9]   G protein-coupled receptors:: In silico drug discovery in 3D [J].
Becker, OM ;
Marantz, Y ;
Shacham, S ;
Inbal, B ;
Heifetz, A ;
Kalid, O ;
Bar-Haim, S ;
Warshaviak, D ;
Fichman, M ;
Noiman, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (31) :11304-11309
[10]   An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression [J].
Becker, Oren M. ;
Dhanoa, Dale S. ;
Marantz, Yael ;
Chen, Dongli ;
Shacham, Sharon ;
Cheruku, Srinivasa ;
Heifetz, Alexander ;
Mohanty, Pradyumna ;
Fichman, Merav ;
Sharadendu, Anurag ;
Nudelman, Raphael ;
Kauffman, Michael ;
Noiman, Silvia .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (11) :3116-3135